Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid. 1982

J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus

Micronized 8-methoxypsoralen (8-MOP), with a smaller crystal size, produced significantly higher serum level profiles than nonmicronized 8-MOP. Furthermore, the absorption of the micronized drug was more rapid, resulting in peak serum levels within 1 h in 75% of the patients. Our blister fluid studies suggest, however, that reduction of the photosensitizer concentration is slower in skin than in serum. This implies that despite markedly reduced 8-MOP serum level after 2 h the skin remains sufficiently sensitized up to that point of time.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008730 Methoxsalen A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation. 8-Methoxypsoralen,Ammoidin,Xanthotoxin,8-MOP,Deltasoralen,Dermox,Geroxalen,Meladinina,Meladinine,Meloxine,Methoxa-Dome,Méladinine,Oxsoralen,Oxsoralen-Ultra,Puvalen,Ultramop,8 MOP,8 Methoxypsoralen,8MOP,Methoxa Dome,Oxsoralen Ultra
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D001768 Blister Visible accumulations of fluid within or beneath the epidermis. Bulla,Vesication,Bleb,Bullae,Bullous Lesion,Blebs,Blisters,Bullous Lesions,Lesion, Bullous,Lesions, Bullous,Vesications

Related Publications

J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus
December 1980, Clinical chemistry,
J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus
February 1988, Photo-dermatology,
J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus
August 1985, Archiv der Pharmazie,
J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus
October 1983, The British journal of dermatology,
J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus
January 1982, European journal of clinical pharmacology,
J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus
January 1985, Chemotherapy,
J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus
January 1982, Archives of dermatological research,
J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus
December 1991, The Journal of antimicrobial chemotherapy,
J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus
January 1987, Drug metabolism and disposition: the biological fate of chemicals,
J Lauharanta, and T Juvakoski, and L Kanerva, and A Lassus
December 1990, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!